Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
40
AVGO Quote, Financials, Valuation and Earnings
Last price:
$287.07
Seasonality move
:
3.11%
Day range:
$275.67 - $281.51
52-week range:
$128.50 - $283.36
Dividend yield:
0.82%
P/E ratio:
105.17x
P/S ratio:
23.57x
P/B ratio:
18.98x
Volume:
15M
Avg. volume:
23.6M
1-year change:
65.79%
Market cap:
$1.3T
Revenue:
$51.6B
EPS (TTM):
$2.67
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $23.9B | $27.5B | $33.2B | $35.8B | $51.6B | |
| Revenue Growth (YoY) | 5.71% | 14.91% | 20.96% | 7.88% | 43.99% | |
| Cost of Revenues | $10.4B | $10.6B | $11.1B | $11.1B | $19.1B | |
| Gross Profit | $13.5B | $16.8B | $22.1B | $24.7B | $32.5B | |
| Gross Profit Margin | 56.58% | 61.36% | 66.55% | 68.93% | 63.03% | |
| R&D Expenses | $5B | $4.9B | $4.9B | $5.3B | $9.3B | |
| Selling, General & Admin | $1.9B | $1.3B | $1.4B | $1.6B | $5B | |
| Other Inc / (Exp) | -$45M | -$33M | -$211M | -$267M | -$1.6B | |
| Operating Expenses | $9.3B | $8.2B | $7.8B | $8.2B | $17.5B | |
| Operating Income | $4.2B | $8.7B | $14.3B | $16.5B | $15B | |
| Net Interest Expenses | $1.7B | $1.9B | $1.6B | $1.1B | $3.5B | |
| EBT. Incl. Unusual Items | $2.4B | $6.8B | $12.4B | $15.1B | $9.9B | |
| Earnings of Discontinued Ops. | -$1M | -- | -- | -- | -$273M | |
| Income Tax Expense | -$518M | $29M | $939M | $1B | $3.7B | |
| Net Income to Company | $3B | $6.7B | $11.5B | $14.1B | $5.9B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3B | $6.7B | $11.5B | $14.1B | $5.9B | |
| Basic EPS (Cont. Ops) | $0.66 | $1.57 | $2.74 | $3.39 | $1.27 | |
| Diluted EPS (Cont. Ops) | $0.63 | $1.50 | $2.65 | $3.30 | $1.23 | |
| Weighted Average Basic Share | $4B | $4.1B | $4.1B | $4.1B | $4.6B | |
| Weighted Average Diluted Share | $4.2B | $4.3B | $4.2B | $4.3B | $4.8B | |
| EBITDA | $11.1B | $14.7B | $19.2B | $20.6B | $23.9B | |
| EBIT | $4.2B | $8.7B | $14.2B | $16.7B | $13.9B | |
| Revenue (Reported) | $23.9B | $27.5B | $33.2B | $35.8B | $51.6B | |
| Operating Income (Reported) | $4.2B | $8.7B | $14.3B | $16.5B | $15B | |
| Operating Income (Adjusted) | $4.2B | $8.7B | $14.2B | $16.7B | $13.9B | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.6B | $8.1B | $8.7B | $12.5B | $15B | |
| Revenue Growth (YoY) | 15.12% | 22.59% | 7.78% | 42.99% | 20.16% | |
| Cost of Revenues | $2.6B | $2.7B | $2.6B | $4.7B | $4.8B | |
| Gross Profit | $4.1B | $5.4B | $6.1B | $7.8B | $10.2B | |
| Gross Profit Margin | 61.38% | 67.12% | 70.02% | 62.27% | 67.96% | |
| R&D Expenses | $1.2B | $1.3B | $1.3B | $2.4B | $2.7B | |
| Selling, General & Admin | $325M | $368M | $438M | $1.3B | $1.1B | |
| Other Inc / (Exp) | -$48M | -$104M | $104M | -$205M | -$61M | |
| Operating Expenses | $2.1B | $2B | $2.1B | $4.5B | $4.3B | |
| Operating Income | $2B | $3.4B | $4B | $3.3B | $5.9B | |
| Net Interest Expenses | $466M | $518M | $405M | $1B | $769M | |
| EBT. Incl. Unusual Items | $1.5B | $2.8B | $3.7B | $2B | $5.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$7M | $200M | $235M | -$116M | $120M | |
| Net Income to Company | $1.5B | $2.6B | $3.5B | $2.1B | $5B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.5B | $2.6B | $3.5B | $2.1B | $5B | |
| Basic EPS (Cont. Ops) | $0.35 | $0.62 | $0.84 | $0.46 | $1.05 | |
| Diluted EPS (Cont. Ops) | $0.33 | $0.59 | $0.82 | $0.44 | $1.03 | |
| Weighted Average Basic Share | $4.1B | $4.1B | $4.2B | $4.6B | $4.7B | |
| Weighted Average Diluted Share | $4.3B | $4.2B | $4.3B | $4.8B | $4.8B | |
| EBITDA | $3.5B | $4.6B | $5.1B | $5.6B | $8B | |
| EBIT | $2B | $3.3B | $4.1B | $3.1B | $5.9B | |
| Revenue (Reported) | $6.6B | $8.1B | $8.7B | $12.5B | $15B | |
| Operating Income (Reported) | $2B | $3.4B | $4B | $3.3B | $5.9B | |
| Operating Income (Adjusted) | $2B | $3.3B | $4.1B | $3.1B | $5.9B | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $25.6B | $30B | $35B | $42.6B | $57B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $10.5B | $10.7B | $11.3B | $14.9B | $19.3B | |
| Gross Profit | $15.1B | $19.3B | $23.7B | $27.7B | $37.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.9B | $4.9B | $5B | $7.5B | $9.5B | |
| Selling, General & Admin | $1.5B | $1.4B | $1.5B | $3.7B | $4.1B | |
| Other Inc / (Exp) | -$62M | -$166M | $161M | -$1.1B | -$1.1B | |
| Operating Expenses | $8.5B | $8B | $7.9B | $13.4B | $16.3B | |
| Operating Income | $6.5B | $11.3B | $15.9B | $14.3B | $21.4B | |
| Net Interest Expenses | $1.9B | $1.8B | $1.5B | $2.2B | $3.2B | |
| EBT. Incl. Unusual Items | $4.6B | $9.4B | $14.5B | $10.9B | $17.1B | |
| Earnings of Discontinued Ops. | -$1M | -- | -- | $51M | -$324M | |
| Income Tax Expense | -$284M | $445M | $825M | $666M | $3.9B | |
| Net Income to Company | $4.9B | $8.9B | $13.7B | $10.3B | $12.9B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $4.9B | $8.9B | $13.7B | $10.3B | $12.9B | |
| Basic EPS (Cont. Ops) | $1.12 | $2.10 | $3.29 | $2.40 | $2.74 | |
| Diluted EPS (Cont. Ops) | $1.07 | $2.01 | $3.19 | $2.32 | $2.67 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $13B | $16.7B | $20.5B | $20.4B | $30.2B | |
| EBIT | $6.5B | $11.1B | $16.1B | $13.7B | $20.8B | |
| Revenue (Reported) | $25.6B | $30B | $35B | $42.6B | $57B | |
| Operating Income (Reported) | $6.5B | $11.3B | $15.9B | $14.3B | $21.4B | |
| Operating Income (Adjusted) | $6.5B | $11.1B | $16.1B | $13.7B | $20.8B | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $13.3B | $15.8B | $17.6B | $24.4B | $29.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $5.3B | $5.3B | $5.5B | $9.3B | $9.6B | |
| Gross Profit | $8B | $10.5B | $12.1B | $15.2B | $20.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2.4B | $2.5B | $2.5B | $4.7B | $4.9B | |
| Selling, General & Admin | $664M | $689M | $786M | $2.8B | $2B | |
| Other Inc / (Exp) | -$2M | -$135M | $237M | -$640M | -$130M | |
| Operating Expenses | $4.1B | $4B | $4B | $9.2B | $8B | |
| Operating Income | $3.9B | $6.5B | $8.1B | $6B | $12.3B | |
| Net Interest Expenses | $1B | $925M | $811M | $2B | $1.6B | |
| EBT. Incl. Unusual Items | $2.9B | $5.5B | $7.6B | $3.3B | $10.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | $51M | -- | |
| Income Tax Expense | -$1M | $415M | $301M | -$48M | $107M | |
| Net Income to Company | $2.9B | $5.1B | $7.3B | $3.4B | $10.5B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.9B | $5.1B | $7.3B | $3.4B | $10.5B | |
| Basic EPS (Cont. Ops) | $0.66 | $1.20 | $1.74 | $0.75 | $2.22 | |
| Diluted EPS (Cont. Ops) | $0.63 | $1.15 | $1.70 | $0.72 | $2.17 | |
| Weighted Average Basic Share | $8.2B | $8.2B | $8.3B | $9.2B | $9.4B | |
| Weighted Average Diluted Share | $8.6B | $8.5B | $8.6B | $9.5B | $9.7B | |
| EBITDA | $6.9B | $9B | $10.3B | $10.2B | $16.6B | |
| EBIT | $3.9B | $6.4B | $8.4B | $5.3B | $12.2B | |
| Revenue (Reported) | $13.3B | $15.8B | $17.6B | $24.4B | $29.9B | |
| Operating Income (Reported) | $3.9B | $6.5B | $8.1B | $6B | $12.3B | |
| Operating Income (Adjusted) | $3.9B | $6.4B | $8.4B | $5.3B | $12.2B | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $7.6B | $12.2B | $12.4B | $14.2B | $9.3B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.3B | $2.1B | $3B | $3.2B | $4.4B | |
| Inventory | $1B | $1.3B | $1.9B | $1.9B | $1.8B | |
| Prepaid Expenses | $387M | $539M | $864M | $743M | $1.4B | |
| Other Current Assets | $590M | $516M | $341M | $364M | $764M | |
| Total Current Assets | $11.9B | $16.6B | $18.5B | $20.8B | $19.6B | |
| Property Plant And Equipment | $2.5B | $2.3B | $2.2B | $2.2B | $2.5B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $43.4B | $43.5B | $43.6B | $43.7B | $97.9B | |
| Other Intangibles | $16.8B | $11.4B | $7.1B | $3.9B | $40.6B | |
| Other Long-Term Assets | $1.3B | $1.8B | $1.8B | $2.3B | $5.1B | |
| Total Assets | $75.9B | $75.6B | $73.2B | $72.9B | $165.6B | |
| Accounts Payable | $836M | $1.1B | $998M | $1.2B | $1.7B | |
| Accrued Expenses | -- | $282M | $393M | $380M | $535M | |
| Current Portion Of Long-Term Debt | -- | $264M | $403M | $1.6B | $1.2B | |
| Current Portion Of Capital Lease Obligations | -- | $26M | $37M | $45M | $26M | |
| Other Current Liabilities | $771M | $397M | $408M | $312M | $1.1B | |
| Total Current Liabilities | $6.4B | $6.3B | $7.1B | $7.4B | $16.7B | |
| Long-Term Debt | $40.2B | $39.4B | $39.1B | $37.6B | $66.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $52B | $50.6B | $50.5B | $48.9B | $98B | |
| Common Stock | $27M | $27M | -- | $4M | $5M | |
| Other Common Equity Adj | -$108M | -$116M | -$54M | $207M | $207M | |
| Common Equity | $23.9B | $25B | $22.7B | $24B | $67.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $23.9B | $25B | $22.7B | $24B | $67.7B | |
| Total Liabilities and Equity | $75.9B | $75.6B | $73.2B | $72.9B | $165.6B | |
| Cash and Short Terms | $7.6B | $12.2B | $12.4B | $14.2B | $9.3B | |
| Total Debt | $41.1B | $39.7B | $39.5B | $39.2B | $67.5B | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $9.5B | $9B | $11.6B | $9.8B | $9.5B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.4B | $3.1B | $3B | $5.5B | $5.6B | |
| Inventory | $1B | $1.7B | $1.9B | $1.8B | $2B | |
| Prepaid Expenses | $604M | $689M | $676M | $1.7B | $936M | |
| Other Current Assets | $694M | $365M | $725M | $1.2B | $959M | |
| Total Current Assets | $14.2B | $14.8B | $17.9B | $25.3B | $22.2B | |
| Property Plant And Equipment | $2.4B | $2.3B | $2.2B | $2.7B | $2.5B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $43.5B | $43.6B | $43.6B | $97.9B | $97.8B | |
| Other Intangibles | $14.1B | $9.2B | $5.4B | $45.4B | $36.4B | |
| Other Long-Term Assets | $1.3B | $1.8B | $2.5B | $4B | $5.8B | |
| Total Assets | $75.5B | $71.7B | $71.7B | $175.2B | $164.6B | |
| Accounts Payable | $830M | $1.1B | $831M | $1.4B | $1.3B | |
| Accrued Expenses | $335M | -- | $382M | $450M | $562M | |
| Current Portion Of Long-Term Debt | -- | $269M | $1.1B | $2.4B | $1.7B | |
| Current Portion Of Capital Lease Obligations | -- | $33M | $40M | $52M | $4M | |
| Other Current Liabilities | $439M | $711M | $470M | $2.8B | $992M | |
| Total Current Liabilities | $6.4B | $6.9B | $7.5B | $20.2B | $20.6B | |
| Long-Term Debt | $40.2B | $39.1B | $38.2B | $71.6B | $61.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $51.6B | $50.7B | $49.7B | $105.3B | $95B | |
| Common Stock | $27M | $27M | -- | -- | $5M | |
| Other Common Equity Adj | -$106M | -$115M | -$182M | $207M | $206M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $24B | $21B | $22B | $70B | $69.6B | |
| Total Liabilities and Equity | $75.5B | $71.7B | $71.7B | $175.2B | $164.6B | |
| Cash and Short Terms | $9.5B | $9B | $11.6B | $9.8B | $9.5B | |
| Total Debt | $40.4B | $39.4B | $39.3B | $73.9B | $67.3B | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3B | $6.7B | $11.5B | $14.1B | $5.9B | |
| Depreciation & Amoritzation | $6.9B | $6B | $5B | $3.8B | $10B | |
| Stock-Based Compensation | $2B | $1.7B | $1.5B | $2.2B | $5.7B | |
| Change in Accounts Receivable | $981M | $210M | -$870M | -$187M | $2.3B | |
| Change in Inventories | -$31M | -$294M | -$627M | $27M | $150M | |
| Cash From Operations | $12.1B | $13.8B | $16.7B | $18.1B | $20B | |
| Capital Expenditures | $463M | $443M | $424M | $452M | $548M | |
| Cash Acquisitions | -$10.7B | $37M | -$246M | -$53M | -$22.5B | |
| Cash From Investing | -$11.1B | -$245M | -$667M | -$689M | -$23.1B | |
| Dividends Paid (Ex Special Dividend) | -$5.5B | -$6.2B | -$7B | -$7.6B | -$9.8B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $27.8B | $9.9B | $1.9B | -- | $40B | |
| Long-Term Debt Repaid | -$20.1B | -$11.5B | -$2.4B | -$403M | -$19.6B | |
| Repurchase of Common Stock | -$765M | -$1.3B | -$8.5B | -$7.7B | -$12.4B | |
| Other Financing Activities | -$69M | -$42M | -$17M | -$12M | -$63M | |
| Cash From Financing | $1.6B | -$9B | -$15.8B | -$15.6B | -$1.7B | |
| Beginning Cash (CF) | $5.1B | $7.6B | $12.2B | $12.4B | $14.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6B | $4.5B | $253M | $1.8B | -$4.8B | |
| Ending Cash (CF) | $7.6B | $12.2B | $12.4B | $14.2B | $9.3B | |
| Levered Free Cash Flow | $11.6B | $13.3B | $16.3B | $17.6B | $19.4B | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.5B | $2.6B | $3.5B | $2.1B | $5B | |
| Depreciation & Amoritzation | $1.5B | $1.3B | $939M | $2.5B | $2.2B | |
| Stock-Based Compensation | $425M | $386M | $513M | $1.5B | $1.8B | |
| Change in Accounts Receivable | $106M | -$536M | $185M | -$513M | -$590M | |
| Change in Inventories | -$52M | -$147M | $13M | $82M | -$109M | |
| Cash From Operations | $3.6B | $4.2B | $4.5B | $4.6B | $6.6B | |
| Capital Expenditures | $126M | $85M | $122M | $132M | $144M | |
| Cash Acquisitions | -$8M | -$234M | -- | -$560M | -- | |
| Cash From Investing | -$126M | -$310M | -$318M | -$706M | -$133M | |
| Dividends Paid (Ex Special Dividend) | -$1.6B | -$1.8B | -$1.9B | -$2.4B | -$2.8B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $1.9B | -- | -- | $630M | |
| Long-Term Debt Repaid | -$1.5B | -$2.1B | -- | -$2B | -- | |
| Repurchase of Common Stock | -$461M | -$3.3B | -$3.4B | -$1.5B | -$4.2B | |
| Other Financing Activities | -$2M | -$5M | -$7M | -$2M | -$4M | |
| Cash From Financing | -$3.5B | -$5.1B | -$5.3B | -$5.9B | -$6.3B | |
| Beginning Cash (CF) | $9.6B | $10.2B | $12.6B | $11.9B | $9.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$34M | -$1.2B | -$1.1B | -$2.1B | $165M | |
| Ending Cash (CF) | $9.5B | $9B | $11.6B | $9.8B | $9.5B | |
| Levered Free Cash Flow | $3.4B | $4.2B | $4.4B | $4.4B | $6.4B | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.9B | $8.9B | $13.7B | $10.3B | $12.9B | |
| Depreciation & Amoritzation | $6.5B | $5.6B | $4.4B | $6.7B | $9.5B | |
| Stock-Based Compensation | $1.8B | $1.6B | $1.7B | $4.3B | $5.8B | |
| Change in Accounts Receivable | $792M | -$653M | $43M | $1.1B | -$45M | |
| Change in Inventories | -$62M | -$663M | -$218M | $56M | -$175M | |
| Cash From Operations | $13.2B | $14.8B | $17.5B | $18.9B | $23.2B | |
| Capital Expenditures | $447M | $389M | $463M | $481M | $538M | |
| Cash Acquisitions | $40M | -$189M | -$12M | -$26B | $3.5B | |
| Cash From Investing | -$394M | -$616M | -$469M | -$26.5B | $2.8B | |
| Dividends Paid (Ex Special Dividend) | -$5.9B | -$6.6B | -$7.4B | -$8.7B | -$10.5B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $16.1B | -- | -- | $30B | $17.5B | |
| Long-Term Debt Repaid | -$21.8B | -$3.1B | -$269M | -$3.1B | -$24.8B | |
| Repurchase of Common Stock | -$1.1B | -$7B | -$7B | -$12.6B | -$8.8B | |
| Other Financing Activities | -$89M | -$20M | -$11M | -$26M | -$97M | |
| Cash From Financing | -$12.5B | -$14.7B | -$14.5B | $5.8B | -$26.4B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $311M | -$513M | $2.5B | -$1.7B | -$337M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $12.8B | $14.4B | $17.1B | $18.5B | $22.7B | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.9B | $5.1B | $7.3B | $3.4B | $10.5B | |
| Depreciation & Amoritzation | $3B | $2.6B | $2B | $4.9B | $4.3B | |
| Stock-Based Compensation | $869M | $773M | $904M | $3B | $3.1B | |
| Change in Accounts Receivable | -$141M | -$1B | -$91M | $1.2B | -$1.1B | |
| Change in Inventories | -$1M | -$370M | $39M | $68M | -$257M | |
| Cash From Operations | $6.7B | $7.7B | $8.5B | $9.4B | $12.7B | |
| Capital Expenditures | $240M | $186M | $225M | $254M | $244M | |
| Cash Acquisitions | -$8M | -$234M | -- | -$26B | -- | |
| Cash From Investing | -$248M | -$619M | -$421M | -$26.2B | -$307M | |
| Dividends Paid (Ex Special Dividend) | -$3.1B | -$3.5B | -$3.8B | -$4.9B | -$5.6B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $9.9B | $1.9B | -- | $30B | $7.6B | |
| Long-Term Debt Repaid | -$10.7B | -$2.4B | -$260M | -$2.9B | -$8.1B | |
| Repurchase of Common Stock | -$686M | -$6.4B | -$4.9B | -$9.8B | -$6.3B | |
| Other Financing Activities | -$30M | -$8M | -$2M | -$16M | -$50M | |
| Cash From Financing | -$4.5B | -$10.3B | -$9B | $12.4B | -$12.2B | |
| Beginning Cash (CF) | $17.2B | $22.4B | $25.1B | $26.1B | $18.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.9B | -$3.2B | -$863M | -$4.4B | $124M | |
| Ending Cash (CF) | $19.1B | $19.2B | $24.2B | $21.7B | $18.8B | |
| Levered Free Cash Flow | $6.4B | $7.5B | $8.3B | $9.1B | $12.4B | |
Get AVGO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AVGO
Sector
P/E ratio
105.17x
23.84x
PEG ratio
6.86x
0.00x
P/B ratio
18.98x
2.31x
Price / LTM sales
23.57x
1.64x
Growth Metrics
AVGO
Sector
Revenue growth
20.16%
3.84%
Earnings growth
134.09%
10.8%
Revenue (5-year growth)
17.94%
6.27%
Earnings forecast
$1.57
$0.12
Profitability
AVGO
Sector
Profitability FY 2024
$32.5B
$77.3M
Return on invested capital
9.39%
0.05%
Return on assets
7.7%
-0.48%
Return on equity
18.85%
0.73%
Earnings Date
Last Earnings Date
Jun
5
Next Earnings Date
Sep
5
Estimated Next Earnings Date
Sep
4
Balance Sheet
AVGO
Sector
Total cash
$9.5B
$48.7M
Short term investments
--
$19.4M
Total assets
$165.6B
$223.8M
Long term debt
$67.3B
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 1.15% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.98% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 8.75% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
